Related Experiment Videos
Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure
Insights
Dobutamine and nitroglycerin improved heart function in heart failure patients. The combination therapy enhanced cardiac index and reduced pulmonary wedge pressure, improving the balance between myocardial oxygen supply and demand.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Chronic congestive heart failure (CHF) presents significant challenges in managing hemodynamic instability.
- Understanding the combined effects of inotropic agents and vasodilators is crucial for optimizing CHF treatment.
Purpose of the Study:
- To compare the separate and combined hemodynamic effects of dobutamine and intravenous (IV) nitroglycerin in patients with chronic congestive heart failure.
- To assess the impact of these interventions on cardiac index, pulmonary wedge pressure, and myocardial oxygen balance.
Main Methods:
- A study involving 12 patients with chronic congestive heart failure (various etiologies).
- Hemodynamic parameters were measured during administration of dobutamine alone, IV nitroglycerin alone, and their combination.
- Key metrics included cardiac index, pulmonary wedge pressure, and double product (heart rate x blood pressure).
Main Results:
- Dobutamine alone significantly increased cardiac index and decreased pulmonary wedge pressure.
- IV nitroglycerin alone also improved cardiac index and reduced pulmonary wedge pressure.
- The combination of dobutamine and nitroglycerin further enhanced cardiac index and significantly reduced pulmonary wedge pressure compared to dobutamine alone, without increasing myocardial oxygen demand (double product).
Conclusions:
- Combined dobutamine and IV nitroglycerin therapy offers significant hemodynamic benefits in patients with chronic congestive heart failure.
- This combination improves ventricular performance and myocardial oxygen supply-demand relationship.
- The findings support the use of combined therapy for enhanced hemodynamic management in heart failure.
Abstract:
The combined and separate hemodynamic effects of dobutamine and IV nitroglycerin were compared in 12 patients with chronic congestive heart failure (nine with ischemic heart disease, two with idiopathic congestive cardiomyopathy, and one with valvular heart disease). Dobutamine (7.1 micrograms/kg/min) increased cardiac index from 2.4 +/- 0.4 to 3.4 +/- 0.9 L/min/m2 (P < 0.001) and decreased pulmonary wedge pressure from 28 +/- 5 to 16 +/- 4 mm Hg (P < 0.001) while nitroglycerin (127 micrograms/min) alone increased cardia index to 2.8 L/min/m2 (P < 0.001) and decreased wedge pressure to 14.3 mm Hg (P < 0.001). With both drugs, cardiac index increased to 3.5 +/- 0.6 L/min/m2; (NS compared to dobutamine alone) wedge pressure decreased to 11 +/- 4L/min/m2 (P < 0.05 compared to dobutamine alone). Those beneficial hemodynamic effects occurred without a significant change in the double product of heart rate and blood pressure, and were associated with an improvement in the transmyocardial gradient. Thus, the greatly enhanced ventricular performance with dobutamine + nitroglycerin was associated with a better relationship between myocardial oxygen demand and supply.